Jie Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jie Li has a total of 267 co-authors. Here are the top co-authors by number of shared publications:
Qingmei Cui
Global Health Research Center, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China
6 shared publications- Wen-Chih Wu
Providence VA Medical Center
6 shared publications Kei Hang Katie Chan
Department of Epidemiology and Centre for Global Cardiometabolic Health, School of Public Health, Brown University, Providence, RI, USA
5 shared publicationsLingyan Dai
Global Health Research Center, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences
5 shared publicationsJoAnn E. Manson
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, and Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
4 shared publicationsQingling Yang
Global Health Research Center, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
4 shared publications
Latest Publications
- Open Access
- 4 August 2026
- Published by Cambridge University Press (CUP) in Epidemiology and Psychiatric Sciences
- Vol. 35, e46
Real-world antipsychotic prescribing patterns and mortality in schizophrenia: a registry cohort study from China
Aims: Schizophrenia is a chronic psychiatric disorder associated with significantly elevated mortality. While antipsychotics are the cornerstone of treatment, their long-term effects on survival remain uncertain, particularly in non-Western populations. We aimed to assess the real-world association between antipsychotic treatment patterns and all-cause mortality among adults with schizophrenia in China. Methods: This population-based cohort study included 435,816 adults from the Community Schizophrenia Registry System of Guangdong Province, China. Patients were classified into four groups: antipsychotic monotherapy, polytherapy, non-antipsychotic treatment and non-drug treatment. Cox proportional hazards models were used to estimate adjusted hazard ratios (aHRs) for mortality. Results: Over a median follow-up of 7.2 years, 73,527 deaths (16.9%) occurred. Antipsychotic polytherapy (57.6%) was the most common regimen, followed by monotherapy (27.6%). Compared with the non-drug group, mortality risks were significantly lower for polytherapy (aHR: 0.18; 95% CI: 0.18–0.19), monotherapy (aHR: 0.24; 95% CI: 0.24–0.25) and non-antipsychotic treatment (aHR: 0.22; 95% CI: 0.21–0.23). Both first- and second-generation antipsychotics showed comparable mortality benefits. While most polytherapy regimens performed similarly to or better than monotherapy, combinations like risperidone–sulpiride were associated with higher mortality. Subgroup analyses showed stronger benefits in women, younger individuals, rural residents and those with less severe illness. Conclusions: Antipsychotic treatment is associated with significantly reduced mortality among patients with schizophrenia in China, with effects varying by patient characteristics and drug regimen.
- 4 August 2026
- Published by Cambridge University Press (CUP) in Epidemiology and Psychiatric Sciences
- Vol. 35, e46
Open AccessReal-world antipsychotic prescribing patterns and mortality in schizophrenia: a registry cohort study from China
Aims: Schizophrenia is a chronic psychiatric disorder associated with significantly elevated mortality. While antipsychotics are the cornerstone of treatment, their long-term effects on survival remain uncertain, particularly in non-Western populations. We aimed to assess the real-world association between antipsychotic treatment patterns and all-cause mortality among adults with schizophrenia in China. Methods: This population-based cohort study included 435,816 adults from the Community Schizophrenia Registry System of Guangdong Province, China. Patients were classified into four groups: antipsychotic monotherapy, polytherapy, non-antipsychotic treatment and non-drug treatment. Cox proportional hazards models were used to estimate adjusted hazard ratios (aHRs) for mortality. Results: Over a median follow-up of 7.2 years, 73,527 deaths (16.9%) occurred. Antipsychotic polytherapy (57.6%) was the most common regimen, followed by monotherapy (27.6%). Compared with the non-drug group, mortality risks were significantly lower for polytherapy (aHR: 0.18; 95% CI: 0.18–0.19), monotherapy (aHR: 0.24; 95% CI: 0.24–0.25) and non-antipsychotic treatment (aHR: 0.22; 95% CI: 0.21–0.23). Both first- and second-generation antipsychotics showed comparable mortality benefits. While most polytherapy regimens performed similarly to or better than monotherapy, combinations like risperidone–sulpiride were associated with higher mortality. Subgroup analyses showed stronger benefits in women, younger individuals, rural residents and those with less severe illness. Conclusions: Antipsychotic treatment is associated with significantly reduced mortality among patients with schizophrenia in China, with effects varying by patient characteristics and drug regimen.
- Open Access
- 14 July 2026
- Published by BMJ in BMJ Nutrition, Prevention & Health
Dietary magnesium and mortality risk associated with smoking and cadmium: evidence from two national population-based studies
Objective: To investigate the associations of blood cadmium levels and smoking status with all-cause and cause-specific mortality and to evaluate whether magnesium intake modifies these associations in two large population-based cohorts. Design: Prospective cohort study. Setting: US National Health and Nutrition Examination Survey (NHANES, 2003–2018) and UK Biobank (UKB). Participants: 35 197 adults from NHANES and 209 615 participants from UKB. Exposures: Blood cadmium concentration (NHANES only), self-reported smoking status, dietary magnesium intake and magnesium supplement use. Main outcome measures: The main outcomes were all-cause, cardiovascular disease (CVD) and cancer mortality, which were obtained through linkage to national death registries. Results: NHANES documented 4412 deaths over a median follow-up of 9.3 years and UKB documented 12 633 deaths over a median follow-up of 13.4 years. In NHANES, compared with adults in the lowest quartile of blood cadmium, those in the highest quartile had higher risks of all-cause (HR (95% CI)1.62 (1.41 to 1.87)), CVD (1.54 (1.19 to 1.98)) and cancer mortality (1.53 (1.14 to 2.05)). Cadmium mediated 31.1% of the effect of smoking on all-cause mortality. High dietary magnesium intake was associated with lower mortality risks, particularly among individuals with high cadmium exposure (HR for all-cause mortality in adults with cadmium ≥median vs <median: 0.81 (0.72 to 0.90) vs 0.91 (0.79 to 1.06); p for additive interaction=0.02) or who smoked (HR for all-cause mortality in smokers vs non-smokers: 0.78 (0.69 to 0.88) vs 0.90 (0.79 to 1.02); p for additive interaction=0.003). No protective association was observed for magnesium supplements. Findings were consistent in UKB, where higher dietary magnesium intake was inversely associated with mortality among smokers. Conclusion: Magnesium intake from food, but not supplements, is associated with reduced mortality risk linked to cadmium exposure and smoking. Public health strategies promoting adequate dietary magnesium intake may help mitigate toxicant-related premature mortality.
- 14 July 2026
- Published by BMJ in BMJ Nutrition, Prevention & Health
Open AccessDietary magnesium and mortality risk associated with smoking and cadmium: evidence from two national population-based studies
Objective: To investigate the associations of blood cadmium levels and smoking status with all-cause and cause-specific mortality and to evaluate whether magnesium intake modifies these associations in two large population-based cohorts. Design: Prospective cohort study. Setting: US National Health and Nutrition Examination Survey (NHANES, 2003–2018) and UK Biobank (UKB). Participants: 35 197 adults from NHANES and 209 615 participants from UKB. Exposures: Blood cadmium concentration (NHANES only), self-reported smoking status, dietary magnesium intake and magnesium supplement use. Main outcome measures: The main outcomes were all-cause, cardiovascular disease (CVD) and cancer mortality, which were obtained through linkage to national death registries. Results: NHANES documented 4412 deaths over a median follow-up of 9.3 years and UKB documented 12 633 deaths over a median follow-up of 13.4 years. In NHANES, compared with adults in the lowest quartile of blood cadmium, those in the highest quartile had higher risks of all-cause (HR (95% CI)1.62 (1.41 to 1.87)), CVD (1.54 (1.19 to 1.98)) and cancer mortality (1.53 (1.14 to 2.05)). Cadmium mediated 31.1% of the effect of smoking on all-cause mortality. High dietary magnesium intake was associated with lower mortality risks, particularly among individuals with high cadmium exposure (HR for all-cause mortality in adults with cadmium ≥median vs <median: 0.81 (0.72 to 0.90) vs 0.91 (0.79 to 1.06); p for additive interaction=0.02) or who smoked (HR for all-cause mortality in smokers vs non-smokers: 0.78 (0.69 to 0.88) vs 0.90 (0.79 to 1.02); p for additive interaction=0.003). No protective association was observed for magnesium supplements. Findings were consistent in UKB, where higher dietary magnesium intake was inversely associated with mortality among smokers. Conclusion: Magnesium intake from food, but not supplements, is associated with reduced mortality risk linked to cadmium exposure and smoking. Public health strategies promoting adequate dietary magnesium intake may help mitigate toxicant-related premature mortality.
- Open Access
- 23 June 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (7) , 644
Epigenetic Patterns in Musculoskeletal Disease: Methylation of DKK1, RHOJ, and SOX6 Genes in Osteoarthritis and Osteoporosis
Osteoarthritis (OA) and osteoporosis (OP) are prevalent conditions with a complex relationship, yet their shared epigenetic mechanisms remain poorly understood. While genes like DKK1, RHOJ, and SOX6 have been implicated in both diseases, the specific role of individual CpG sites has not been fully characterized. We investigated CpG methylation in these genes using bisulfite pyrosequencing of peripheral blood DNA from n = 96 postmenopausal women: n = 24 with comorbid OA and OP, n = 34 with OA, and n = 38 healthy controls. Methylation differences were analyzed using statistical tests and logistic regression. Comorbid patients showed significant hypermethylation at two DKK1 CpG sites compared to the OA-only group (padj = 0.0007 and padj = 0.042). Conversely, one DKK1 site was hypomethylated in the OA-only group relative to controls (padj = 0.03). A regression model combining three DKK1 sites and one SOX6 site demonstrated predictive value for comorbid disease, with an AUC of 0.696. These findings identify site-specific methylation of DKK1 and SOX6 as a molecular signature associated with comorbid OA and OP, offering new insights into their shared etiology.
- 23 June 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (7) , 644
Open AccessEpigenetic Patterns in Musculoskeletal Disease: Methylation of DKK1, RHOJ, and SOX6 Genes in Osteoarthritis and Osteoporosis
Osteoarthritis (OA) and osteoporosis (OP) are prevalent conditions with a complex relationship, yet their shared epigenetic mechanisms remain poorly understood. While genes like DKK1, RHOJ, and SOX6 have been implicated in both diseases, the specific role of individual CpG sites has not been fully characterized. We investigated CpG methylation in these genes using bisulfite pyrosequencing of peripheral blood DNA from n = 96 postmenopausal women: n = 24 with comorbid OA and OP, n = 34 with OA, and n = 38 healthy controls. Methylation differences were analyzed using statistical tests and logistic regression. Comorbid patients showed significant hypermethylation at two DKK1 CpG sites compared to the OA-only group (padj = 0.0007 and padj = 0.042). Conversely, one DKK1 site was hypomethylated in the OA-only group relative to controls (padj = 0.03). A regression model combining three DKK1 sites and one SOX6 site demonstrated predictive value for comorbid disease, with an AUC of 0.696. These findings identify site-specific methylation of DKK1 and SOX6 as a molecular signature associated with comorbid OA and OP, offering new insights into their shared etiology.
- Open Access
- 1 May 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-13
Global Patterns and Temporal Trends in Modifiable Risk Factors Among Women of Childbearing Age, 1990–2021: A Systematic Analysis from the Global Burden of Disease Study
Women of childbearing age (WCBA, 15–49 years) are a key population for public health prevention, yet evidence on long-term trends in modifiable risk factors and their attributable burden remains limited. We aimed to assess global patterns and temporal changes in major modifiable risk factors among WCBA. Using data from the Global Burden of Disease (GBD) 2021, we analysed summary exposure values, deaths, and disability-adjusted life years (DALYs) attributable to 83 modifiable risk factors across metabolic, behavioural, and environmental/occupational domains. In 2021, 1.10 million deaths and 108.0 million DALYs among WCBA were attributable to modifiable risk factors, representing 34.83% of total deaths and 26.52% of total DALYs. The leading Level 3 risk factors for DALYs were unsafe sex (4.89%), iron deficiency (3.36%), high body mass index (BMI) (3.19%), and high fasting plasma glucose (FPG) (2.48%). Between 1990 and 2021, environmental and occupational risk exposures generally declined over time, whereas metabolic risk exposures—particularly high BMI (EAPC 1.83%) and high FPG (EAPC 1.59%)—showed sustained increases across most regions. Risk profiles varied across sociodemographic index (SDI) levels, with reproductive and nutritional risks predominating in lower-SDI settings and metabolic or behavioural risks more prominent in higher-SDI settings. Modifiable risk factors account for a substantial proportion of disease burden among WCBA. The coexistence of rising metabolic risks and persistent reproductive and nutritional challenges calls for targeted strategies—strengthening reproductive health and nutrition programmes in lower-SDI settings, and prioritising obesity prevention and metabolic screening in higher-SDI regions.
- 1 May 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-13
Open AccessGlobal Patterns and Temporal Trends in Modifiable Risk Factors Among Women of Childbearing Age, 1990–2021: A Systematic Analysis from the Global Burden of Disease Study
Women of childbearing age (WCBA, 15–49 years) are a key population for public health prevention, yet evidence on long-term trends in modifiable risk factors and their attributable burden remains limited. We aimed to assess global patterns and temporal changes in major modifiable risk factors among WCBA. Using data from the Global Burden of Disease (GBD) 2021, we analysed summary exposure values, deaths, and disability-adjusted life years (DALYs) attributable to 83 modifiable risk factors across metabolic, behavioural, and environmental/occupational domains. In 2021, 1.10 million deaths and 108.0 million DALYs among WCBA were attributable to modifiable risk factors, representing 34.83% of total deaths and 26.52% of total DALYs. The leading Level 3 risk factors for DALYs were unsafe sex (4.89%), iron deficiency (3.36%), high body mass index (BMI) (3.19%), and high fasting plasma glucose (FPG) (2.48%). Between 1990 and 2021, environmental and occupational risk exposures generally declined over time, whereas metabolic risk exposures—particularly high BMI (EAPC 1.83%) and high FPG (EAPC 1.59%)—showed sustained increases across most regions. Risk profiles varied across sociodemographic index (SDI) levels, with reproductive and nutritional risks predominating in lower-SDI settings and metabolic or behavioural risks more prominent in higher-SDI settings. Modifiable risk factors account for a substantial proportion of disease burden among WCBA. The coexistence of rising metabolic risks and persistent reproductive and nutritional challenges calls for targeted strategies—strengthening reproductive health and nutrition programmes in lower-SDI settings, and prioritising obesity prevention and metabolic screening in higher-SDI regions.
- Open Access
- 1 May 2026
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 9 (5) , e2610823
Maternal Cardiac Disease and Congenital Heart Disease Risk in Offspring
Importance: Maternal adult congenital heart disease (ACHD) has been associated with increased offspring congenital heart disease (CHD), but evidence from resource-limited regions remains scarce. The association between maternal acquired heart disease (AHD) and offspring CHD is unknown. Objective: To quantify the overall and subtype-specific CHD risk in offspring associated with maternal ACHD and AHD, examine the association of maternal ACHD and AHD with outcomes in offspring with CHD, and identify maternal factors that may modify the associations between maternal cardiac diseases and offspring CHD risk. Design, Setting, and Participants: This prospective birth cohort study enrolled pregnant women receiving prenatal care between August 1, 2011, and December 31, 2021, at a major cardiac referral center in China. Participants included pregnant women with ACHD, with AHD, or without cardiac disease and were followed up through delivery; their offspring were followed up until 1 year of age. All follow-ups were completed by December 15, 2023. Data were analyzed from April 1, 2024, through April 31, 2025. Exposures: Maternal ACHD and AHD, confirmed via the center’s electronic medical records. Main Outcomes and Measures: The main outcome was offspring CHD, which was diagnosed using echocardiography. Log-binomial regression was used to estimate relative risks (risk ratios [RRs]) and 95% CIs. Adverse outcomes were compared using pairwise tests. Stratification analyses identified potential effect modifiers. Results: A total of 14 336 pregnant women with 15 677 offspring (8480 males [54.1%]) were included. The mean (SD) maternal age and gestational age at enrollment were 31.4 (4.5) years and 16.4 (6.4) weeks, respectively. Both maternal ACHD and AHD were associated with higher CHD risk in offspring (RR, 1.71 [95% CI, 1.26-2.31] and 1.38 [95% CI, 1.02-1.87], respectively). Minor CHDs, particularly septal defects, were the subtypes with the greatest magnitude of associations with maternal ACHD (RR, 2.95; 95% CI, 1.97-4.43) and AHD (RR, 2.28; 95% CI, 1.50-3.45). Right ventricular outflow tract obstruction (RR, 6.17; 95% CI, 3.59-10.60) and valvular heart disease (RR, 1.65; 95% CI, 1.11-2.45) were the key contributors to offspring CHD risk. Preterm birth had higher rates among offspring with CHD and mothers with ACHD as well as offspring with CHD and mothers without ACHD compared with offspring without CHD and mothers without cardiac disease (12 of 39 [30.8%] and 121 of 780 [15.5%] vs 1287 of 14 088 [9.1%]; all P < .001). Higher rates of chromosomal (5 of 39 [12.8%] and 38 of 780 [4.9%] vs 75 of 14 088 [0.5%]; all P < .001) and genetic aberrations (3 of 39 [7.7%] and 16 of 780 [2.1%] vs 57/14 088 [0.4%]; all P < .001) were found among offspring with CHD and mothers with AHD as well as offspring with CHD and mothers without AHCD compared with offspring without CHD and mothers without cardiac disease. Associations between maternal cardiac disease and offspring CHD were robust in primiparous women (ACHD: RR, 2.15 [95% CI, 1.48-3.11], P for interaction < .001; AHD: RR, 1.73 [95% CI, 1.17-2.56], P for interaction = .02) and those with periconceptional exposure to hazardous substances (ACHD: RR, 2.22 [95% CI, 1.56-3.16], P for interaction < .001; AHD: RR, 1.57 [95% CI, 1.05-2.36], P for interaction = .02). Conclusions and Relevance: In this cohort study, maternal ACHD and AHD were associated with increased risks and adverse outcomes of offspring CHD. Targeted modification of identified maternal factors could help mitigate offspring CHD risk in this high-risk population.
- 1 May 2026
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 9 (5) , e2610823
Open AccessMaternal Cardiac Disease and Congenital Heart Disease Risk in Offspring
Importance: Maternal adult congenital heart disease (ACHD) has been associated with increased offspring congenital heart disease (CHD), but evidence from resource-limited regions remains scarce. The association between maternal acquired heart disease (AHD) and offspring CHD is unknown. Objective: To quantify the overall and subtype-specific CHD risk in offspring associated with maternal ACHD and AHD, examine the association of maternal ACHD and AHD with outcomes in offspring with CHD, and identify maternal factors that may modify the associations between maternal cardiac diseases and offspring CHD risk. Design, Setting, and Participants: This prospective birth cohort study enrolled pregnant women receiving prenatal care between August 1, 2011, and December 31, 2021, at a major cardiac referral center in China. Participants included pregnant women with ACHD, with AHD, or without cardiac disease and were followed up through delivery; their offspring were followed up until 1 year of age. All follow-ups were completed by December 15, 2023. Data were analyzed from April 1, 2024, through April 31, 2025. Exposures: Maternal ACHD and AHD, confirmed via the center’s electronic medical records. Main Outcomes and Measures: The main outcome was offspring CHD, which was diagnosed using echocardiography. Log-binomial regression was used to estimate relative risks (risk ratios [RRs]) and 95% CIs. Adverse outcomes were compared using pairwise tests. Stratification analyses identified potential effect modifiers. Results: A total of 14 336 pregnant women with 15 677 offspring (8480 males [54.1%]) were included. The mean (SD) maternal age and gestational age at enrollment were 31.4 (4.5) years and 16.4 (6.4) weeks, respectively. Both maternal ACHD and AHD were associated with higher CHD risk in offspring (RR, 1.71 [95% CI, 1.26-2.31] and 1.38 [95% CI, 1.02-1.87], respectively). Minor CHDs, particularly septal defects, were the subtypes with the greatest magnitude of associations with maternal ACHD (RR, 2.95; 95% CI, 1.97-4.43) and AHD (RR, 2.28; 95% CI, 1.50-3.45). Right ventricular outflow tract obstruction (RR, 6.17; 95% CI, 3.59-10.60) and valvular heart disease (RR, 1.65; 95% CI, 1.11-2.45) were the key contributors to offspring CHD risk. Preterm birth had higher rates among offspring with CHD and mothers with ACHD as well as offspring with CHD and mothers without ACHD compared with offspring without CHD and mothers without cardiac disease (12 of 39 [30.8%] and 121 of 780 [15.5%] vs 1287 of 14 088 [9.1%]; all P < .001). Higher rates of chromosomal (5 of 39 [12.8%] and 38 of 780 [4.9%] vs 75 of 14 088 [0.5%]; all P < .001) and genetic aberrations (3 of 39 [7.7%] and 16 of 780 [2.1%] vs 57/14 088 [0.4%]; all P < .001) were found among offspring with CHD and mothers with AHD as well as offspring with CHD and mothers without AHCD compared with offspring without CHD and mothers without cardiac disease. Associations between maternal cardiac disease and offspring CHD were robust in primiparous women (ACHD: RR, 2.15 [95% CI, 1.48-3.11], P for interaction < .001; AHD: RR, 1.73 [95% CI, 1.17-2.56], P for interaction = .02) and those with periconceptional exposure to hazardous substances (ACHD: RR, 2.22 [95% CI, 1.56-3.16], P for interaction < .001; AHD: RR, 1.57 [95% CI, 1.05-2.36], P for interaction = .02). Conclusions and Relevance: In this cohort study, maternal ACHD and AHD were associated with increased risks and adverse outcomes of offspring CHD. Targeted modification of identified maternal factors could help mitigate offspring CHD risk in this high-risk population.
- Open Access
- 29 January 2026
- Published by Korean Diabetes Association in Diabetes & Metabolism Journal
- Vol. 50 (5) , 977-989
Birth Weight, Adult Fat Distribution, and Type 2 Diabetes Mellitus Risk: Sex-Specific Study in a Large Prospective Cohort
Background: Regional fat distribution is a key determinant of metabolic risk, independent of total adiposity. However, the developmental origins of fat depot-specific accumulation and its contribution to type 2 diabetes mellitus (T2DM) remain unclear. We aimed to investigate whether adult fat distribution mediates the association between birth weight (BW) and T2DM risk.Methods: We analyzed 30,718 diabetes-free UK Biobank participants with magnetic resonance imaging/dual-energy X-ray absorptiometry derived measures of visceral adipose tissue (VAT), abdominal subcutaneous adipose tissue, and gynoid adipose tissue (GAT), liver fat fraction (LFF), pancreatic fat fraction (PFF), and muscle fat infiltration (MFI). Fat depots were adjusted for body mass index (BMI) using sex-specific residuals. Cox regression assessed associations of BW and fat depots with T2DM risk. Mediation analysis assessed indirect effects of fat distribution.Results: Lower BW was associated with a higher risk of T2DM (hazard ratio per 1 kg increase, 0.71; 95% confidence interval, 0.64 to 0.79), with stronger effects in women. Lower BW was linked to greater VAT, LFF, and PFF, and lower GAT, independent of BMI. Higher levels of VAT, LFF, and PFF were associated with increased T2DM risk, while GAT was protective. Mediation analysis revealed that fat distribution partially mediated the BW-T2DM relationship, with LFF showing the strongest mediation effect (11%). Mediation patterns differed by sex: LFF and VAT were the predominant mediators in women, while LFF and GAT contributed substantially in men.Conclusion: Fat distribution—particularly liver and visceral fat—partially mediates the BW-T2DM relationship, independent of BMI. These findings highlight the clinical importance of fat depot profiling in understanding the developmental origins of diabetes and guiding early risk stratification.
- 29 January 2026
- Published by Korean Diabetes Association in Diabetes & Metabolism Journal
- Vol. 50 (5) , 977-989
Open AccessBirth Weight, Adult Fat Distribution, and Type 2 Diabetes Mellitus Risk: Sex-Specific Study in a Large Prospective Cohort
Background: Regional fat distribution is a key determinant of metabolic risk, independent of total adiposity. However, the developmental origins of fat depot-specific accumulation and its contribution to type 2 diabetes mellitus (T2DM) remain unclear. We aimed to investigate whether adult fat distribution mediates the association between birth weight (BW) and T2DM risk.Methods: We analyzed 30,718 diabetes-free UK Biobank participants with magnetic resonance imaging/dual-energy X-ray absorptiometry derived measures of visceral adipose tissue (VAT), abdominal subcutaneous adipose tissue, and gynoid adipose tissue (GAT), liver fat fraction (LFF), pancreatic fat fraction (PFF), and muscle fat infiltration (MFI). Fat depots were adjusted for body mass index (BMI) using sex-specific residuals. Cox regression assessed associations of BW and fat depots with T2DM risk. Mediation analysis assessed indirect effects of fat distribution.Results: Lower BW was associated with a higher risk of T2DM (hazard ratio per 1 kg increase, 0.71; 95% confidence interval, 0.64 to 0.79), with stronger effects in women. Lower BW was linked to greater VAT, LFF, and PFF, and lower GAT, independent of BMI. Higher levels of VAT, LFF, and PFF were associated with increased T2DM risk, while GAT was protective. Mediation analysis revealed that fat distribution partially mediated the BW-T2DM relationship, with LFF showing the strongest mediation effect (11%). Mediation patterns differed by sex: LFF and VAT were the predominant mediators in women, while LFF and GAT contributed substantially in men.Conclusion: Fat distribution—particularly liver and visceral fat—partially mediates the BW-T2DM relationship, independent of BMI. These findings highlight the clinical importance of fat depot profiling in understanding the developmental origins of diabetes and guiding early risk stratification.
- Open Access
- 18 January 2026
- Published by Sechenov University in The Eurasian Journal of Life Sciences
- Vol. 1 (2) , 65-71
Analysis of molecular genetic markers of connective tissue dysplasia
Introduction. Connective tissue dysplasia (CTD) is a hereditary, multifactorial condition characterized by impaired development of connective tissue during the embryonic and postnatal periods. This impairment results from genetically determined defects in the formation, maturation, and metabolism of cells and the extracellular matrix. The aim of this study was to investigate the associations of three polymorphic variants of the ADAMTS5 gene with CTD in general, and with specific phenotypic features of CTD. Materials and Methods. A cross-sectional study was conducted. The study included 181 participants (35 males, 19.3%, 146 females, 80.7%) with a mean age of 21.9 with a standard deviation of 2.9 years. At the first stage, all participants underwent a clinical examination, and signs of CTD were assessed using the Kadurina T.I. score, as modified by Tyurin A.V. The subsequent stage involved a molecular genetic analysis. Statistical data processing was performed using Excel 2024 and GraphPad Prism 8 software packages. Results. The clinical examination, utilizing quantitative scoring methods, revealed signs of CTD in 130 subjects (71.8%). A comparative analysis of the allele and genotype frequency distributions for the ADAMTS5 gene loci (rs226794, rs9978597, and rs2830585) revealed the following significant associations: the A allele and AA genotype of rs226794 with the presence of internal organ hernias (p=0.015 and p=0.007, respectively); the T allele and TT genotype of rs9978597 with CTD (p=0.003 and p=0.004, respectively); and the T allele and TT genotype with skin hyperelasticity (p=0.03 and p=0.03, respectively) and hypotension (p=0.015 and p=0.02, respectively). Conclusion. Thus, the polymorphic variant rs226794 of the ADAMTS5 gene is a risk marker for the development of internal organ hernias, while rs9978597 is a risk marker for CTD, skin hyperelasticity, and hypotension.
- 18 January 2026
- Published by Sechenov University in The Eurasian Journal of Life Sciences
- Vol. 1 (2) , 65-71
Open AccessAnalysis of molecular genetic markers of connective tissue dysplasia
Introduction. Connective tissue dysplasia (CTD) is a hereditary, multifactorial condition characterized by impaired development of connective tissue during the embryonic and postnatal periods. This impairment results from genetically determined defects in the formation, maturation, and metabolism of cells and the extracellular matrix. The aim of this study was to investigate the associations of three polymorphic variants of the ADAMTS5 gene with CTD in general, and with specific phenotypic features of CTD. Materials and Methods. A cross-sectional study was conducted. The study included 181 participants (35 males, 19.3%, 146 females, 80.7%) with a mean age of 21.9 with a standard deviation of 2.9 years. At the first stage, all participants underwent a clinical examination, and signs of CTD were assessed using the Kadurina T.I. score, as modified by Tyurin A.V. The subsequent stage involved a molecular genetic analysis. Statistical data processing was performed using Excel 2024 and GraphPad Prism 8 software packages. Results. The clinical examination, utilizing quantitative scoring methods, revealed signs of CTD in 130 subjects (71.8%). A comparative analysis of the allele and genotype frequency distributions for the ADAMTS5 gene loci (rs226794, rs9978597, and rs2830585) revealed the following significant associations: the A allele and AA genotype of rs226794 with the presence of internal organ hernias (p=0.015 and p=0.007, respectively); the T allele and TT genotype of rs9978597 with CTD (p=0.003 and p=0.004, respectively); and the T allele and TT genotype with skin hyperelasticity (p=0.03 and p=0.03, respectively) and hypotension (p=0.015 and p=0.02, respectively). Conclusion. Thus, the polymorphic variant rs226794 of the ADAMTS5 gene is a risk marker for the development of internal organ hernias, while rs9978597 is a risk marker for CTD, skin hyperelasticity, and hypotension.
- Open Access
- 1 September 2025
- Published by Korean Diabetes Association in Diabetes & Metabolism Journal
- Vol. 49 (5) , 1075-1086
Birth Weight, Cardiovascular Health, and Microvascular Complications in Individuals with Diabetes Mellitus
Background: Diabetes often leads to microvascular complications, including nephropathy, neuropathy, and retinopathy. Understanding the impact of early-life factors like birth weight and modifiable behaviors such as cardiovascular health (CVH) is essential for preventing these complications.Methods: We included 11,515 participants with diabetes but without microvascular complications at baseline from the UK Biobank Study. CVH was evaluated using the Life’s Essential 8 score. Independent and joint associations of birth weight and CVH with microvascular complications were analyzed using Cox proportional hazard models. Two-sample Mendelian randomization (MR) analyses estimated unconfounded associations between birth weight and microvascular complications.Results: Over a median follow-up of 13.1 years, 3,010 microvascular complications occurred. Compared with normal birth weight (2.5–4.0 kg), low birth weight (LBW; 4.0 kg) was not associated with the risk of diabetic microvascular complications. MR analysis confirmed the association between LBW and nephropathy. Adherence to high CVH was associated with a reduced risk of microvascular complications compared to low CVH, regardless of birth weight. The HRs were 0.70 (95% CI, 0.59 to 0.84) for the LBW group and 0.74 (95% CI, 0.68 to 0.80) for the group with birth weight ≥2.5 kg (P for interaction=0.69).Conclusion: LBW was an independent risk factor for nephropathy among diabetic patients. However, the detrimental effects of LBW might be mitigated by improvement in CVH.
- 1 September 2025
- Published by Korean Diabetes Association in Diabetes & Metabolism Journal
- Vol. 49 (5) , 1075-1086
Open AccessBirth Weight, Cardiovascular Health, and Microvascular Complications in Individuals with Diabetes Mellitus
Background: Diabetes often leads to microvascular complications, including nephropathy, neuropathy, and retinopathy. Understanding the impact of early-life factors like birth weight and modifiable behaviors such as cardiovascular health (CVH) is essential for preventing these complications.Methods: We included 11,515 participants with diabetes but without microvascular complications at baseline from the UK Biobank Study. CVH was evaluated using the Life’s Essential 8 score. Independent and joint associations of birth weight and CVH with microvascular complications were analyzed using Cox proportional hazard models. Two-sample Mendelian randomization (MR) analyses estimated unconfounded associations between birth weight and microvascular complications.Results: Over a median follow-up of 13.1 years, 3,010 microvascular complications occurred. Compared with normal birth weight (2.5–4.0 kg), low birth weight (LBW; 4.0 kg) was not associated with the risk of diabetic microvascular complications. MR analysis confirmed the association between LBW and nephropathy. Adherence to high CVH was associated with a reduced risk of microvascular complications compared to low CVH, regardless of birth weight. The HRs were 0.70 (95% CI, 0.59 to 0.84) for the LBW group and 0.74 (95% CI, 0.68 to 0.80) for the group with birth weight ≥2.5 kg (P for interaction=0.69).Conclusion: LBW was an independent risk factor for nephropathy among diabetic patients. However, the detrimental effects of LBW might be mitigated by improvement in CVH.
- 15 July 2025
- Published by Springer Nature in Osteoporosis International
- Vol. 36 (10) , 1977-1986
Testosterone, sex hormone-binding globulin, and fracture risk in men: evidence from observational and Mendelian randomization analyses
Summary Both observational and factorial Mendelian randomization analysis revealed that the combined exposure to higher TT and lower SHBG was associated with decreased risk of fracture. These findings suggest that considering both TT and SHBG—rather than focusing on testosterone alone—may improve fracture risk assessment. Purpose Lower total testosterone (TT) levels have been associated with increased fracture risk in aging men, yet the benefits of testosterone supplementation remain uncertain. This study aimed to assess the joint contributions of TT and sex hormone-binding globulin (SHBG) to fracture risk using both observational and genetic approaches. Methods We included 162,786 men from the UK Biobank, with baseline serum TT and SHBG measurements and genetic data. Cox proportional hazards models were used to estimate associations of TT and SHBG with incident fractures. A 2 × 2 factorial Mendelian randomization (MR) analysis was conducted to evaluate the combined genetic effects of increased TT and decreased SHBG on fracture risk. Results The median age at baseline was 59.0 years, and 7493 men experienced fractures during 13.3 years follow-up. The association between serum TT levels and incident fracture was significantly affected by adjustment for SHBG. Compared to the lowest quintile of Bio-T levels, the adjusted hazard ratio (HR) for total fracture in the highest quintile was 0.72 (95% CI: 0.67, 0.78). In factorial MR analysis, men with genetically higher TT and lower SHBG had significantly lower odds of total fracture (OR: 0.87, 95% CI: 0.80–0.95) compared to those with genetically lower TT and higher SHBG. No association was observed in groups with only high TT or only low SHBG. Conclusion Our findings suggest that the interplay between TT and SHBG is important in determining fracture risk, highlighting the potential clinical value of jointly assessing them to improve fracture risk stratification in men.
- 15 July 2025
- Published by Springer Nature in Osteoporosis International
- Vol. 36 (10) , 1977-1986
Testosterone, sex hormone-binding globulin, and fracture risk in men: evidence from observational and Mendelian randomization analyses
Summary Both observational and factorial Mendelian randomization analysis revealed that the combined exposure to higher TT and lower SHBG was associated with decreased risk of fracture. These findings suggest that considering both TT and SHBG—rather than focusing on testosterone alone—may improve fracture risk assessment. Purpose Lower total testosterone (TT) levels have been associated with increased fracture risk in aging men, yet the benefits of testosterone supplementation remain uncertain. This study aimed to assess the joint contributions of TT and sex hormone-binding globulin (SHBG) to fracture risk using both observational and genetic approaches. Methods We included 162,786 men from the UK Biobank, with baseline serum TT and SHBG measurements and genetic data. Cox proportional hazards models were used to estimate associations of TT and SHBG with incident fractures. A 2 × 2 factorial Mendelian randomization (MR) analysis was conducted to evaluate the combined genetic effects of increased TT and decreased SHBG on fracture risk. Results The median age at baseline was 59.0 years, and 7493 men experienced fractures during 13.3 years follow-up. The association between serum TT levels and incident fracture was significantly affected by adjustment for SHBG. Compared to the lowest quintile of Bio-T levels, the adjusted hazard ratio (HR) for total fracture in the highest quintile was 0.72 (95% CI: 0.67, 0.78). In factorial MR analysis, men with genetically higher TT and lower SHBG had significantly lower odds of total fracture (OR: 0.87, 95% CI: 0.80–0.95) compared to those with genetically lower TT and higher SHBG. No association was observed in groups with only high TT or only low SHBG. Conclusion Our findings suggest that the interplay between TT and SHBG is important in determining fracture risk, highlighting the potential clinical value of jointly assessing them to improve fracture risk stratification in men.
- Open Access
- 1 July 2025
- Published by BMJ in Open Heart
- Vol. 12 (2) , e003561
Impact of birth weight on cardiovascular disease and mediating role of metabolic traits: a Mendelian randomisation study
Background: Birth weight (BW) has been linked to cardiometabolic diseases, but causal associations with a comprehensive range of cardiovascular outcomes and underlying metabolic mechanisms remain unclear. Methods: We applied a two-sample Mendelian randomisation (MR) approach to evaluate causal relationships between genetically predicted BW and 16 distinct cardiovascular diseases (CVD). We further conducted a two-step MR mediation analysis to quantify the mediating roles of 24 metabolic traits covering body composition, glucose metabolism, lipid metabolism, blood pressure, fatty acids and amino acids. Results: Genetically lower BW was associated with higher risks of coronary heart disease (OR 0.72, 95% CI 0.65 to 0.81), myocardial infarction (OR 0.71, 95% CI 0.63 to 0.80) and angina pectoris (OR 0.81, 95% CI 0.72 to 0.90). These effects were partly mediated by type 2 diabetes, systolic blood pressure, total cholesterol and triglycerides, explaining 11.76–33.33% of the total associations. In contrast, genetically higher BW increased the risk of aortic aneurysm (OR 1.46, 95% CI 1.21 to 1.75), venous thromboembolism (OR 1.22, 95% CI 1.09 to 1.36) and atrial fibrillation (OR 1.34, 95% CI 1.21 to 1.48). These associations were partly explained by body composition traits, with appendicular lean mass and body mass index mediating 10.53–26.32% of the effect on aortic aneurysm, 15.79–68.42% of the effect on venous thromboembolism and 10.34–58.62% of the effect on atrial fibrillation. Conclusions: Our study provides robust evidence of distinct causal pathways linking BW with adult cardiovascular risks through specific metabolic mediators. These findings highlight the importance of optimal fetal growth and lifelong metabolic health management as critical strategies to reduce CVD burden.
- 1 July 2025
- Published by BMJ in Open Heart
- Vol. 12 (2) , e003561
Open AccessImpact of birth weight on cardiovascular disease and mediating role of metabolic traits: a Mendelian randomisation study
Background: Birth weight (BW) has been linked to cardiometabolic diseases, but causal associations with a comprehensive range of cardiovascular outcomes and underlying metabolic mechanisms remain unclear. Methods: We applied a two-sample Mendelian randomisation (MR) approach to evaluate causal relationships between genetically predicted BW and 16 distinct cardiovascular diseases (CVD). We further conducted a two-step MR mediation analysis to quantify the mediating roles of 24 metabolic traits covering body composition, glucose metabolism, lipid metabolism, blood pressure, fatty acids and amino acids. Results: Genetically lower BW was associated with higher risks of coronary heart disease (OR 0.72, 95% CI 0.65 to 0.81), myocardial infarction (OR 0.71, 95% CI 0.63 to 0.80) and angina pectoris (OR 0.81, 95% CI 0.72 to 0.90). These effects were partly mediated by type 2 diabetes, systolic blood pressure, total cholesterol and triglycerides, explaining 11.76–33.33% of the total associations. In contrast, genetically higher BW increased the risk of aortic aneurysm (OR 1.46, 95% CI 1.21 to 1.75), venous thromboembolism (OR 1.22, 95% CI 1.09 to 1.36) and atrial fibrillation (OR 1.34, 95% CI 1.21 to 1.48). These associations were partly explained by body composition traits, with appendicular lean mass and body mass index mediating 10.53–26.32% of the effect on aortic aneurysm, 15.79–68.42% of the effect on venous thromboembolism and 10.34–58.62% of the effect on atrial fibrillation. Conclusions: Our study provides robust evidence of distinct causal pathways linking BW with adult cardiovascular risks through specific metabolic mediators. These findings highlight the importance of optimal fetal growth and lifelong metabolic health management as critical strategies to reduce CVD burden.